- Home
- DTST vs PULM Comparison
DTST vs PULM Comparison
Compare DTST & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- PULM
- Stock Information
- Founded
- DTST 2001
- PULM 2003
- Country
- DTST United States
- PULM United States
- Employees
- DTST N/A
- PULM N/A
- Industry
- DTST EDP Services
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- PULM Health Care
- Exchange
- DTST Nasdaq
- PULM Nasdaq
- Market Cap
- DTST 33.4M
- PULM 20.5M
- IPO Year
- DTST N/A
- PULM N/A
- Fundamental
- Price
- DTST $4.66
- PULM $5.57
- Analyst Decision
- DTST
- PULM
- Analyst Count
- DTST 0
- PULM 0
- Target Price
- DTST N/A
- PULM N/A
- AVG Volume (30 Days)
- DTST 977.3K
- PULM 10.9K
- Earning Date
- DTST 08-13-2025
- PULM 08-12-2025
- Dividend Yield
- DTST N/A
- PULM N/A
- EPS Growth
- DTST N/A
- PULM N/A
- EPS
- DTST 0.02
- PULM N/A
- Revenue
- DTST $25,219,312.00
- PULM $1,921,000.00
- Revenue This Year
- DTST $12.57
- PULM N/A
- Revenue Next Year
- DTST $9.29
- PULM $134.88
- P/E Ratio
- DTST $199.27
- PULM N/A
- Revenue Growth
- DTST N/A
- PULM N/A
- 52 Week Low
- DTST $2.93
- PULM $1.78
- 52 Week High
- DTST $5.57
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- DTST 59.10
- PULM 36.25
- Support Level
- DTST $4.54
- PULM $5.20
- Resistance Level
- DTST $5.42
- PULM $6.15
- Average True Range (ATR)
- DTST 0.33
- PULM 0.30
- MACD
- DTST 0.02
- PULM -0.05
- Stochastic Oscillator
- DTST 62.68
- PULM 22.70
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).